Trial Information

Summary: Thearpy for Partial Seizures

We are conducting a clinical research study for voluteers diagnosed with Epilepsy experiencing partial seizures while on anti-epileptic medications. This study tests the efficacy, safety and tolerability of an investigational drug as adjunctive therapy in subjects with Refractory partial seizures.

Study Criteria:

• Age 16+
• Diagnosed with Epilepsy for at least 1 year with partial seizures
• CT or MRI within the past 5 years
• History of inadequate response to at least 1 AED
• Current treatment with 1 to 2 approved antiepileptic drugs and taking a stable dose for 2 months prior to screening
• Vagal nerve stimulator (VNS) is not considered an AED
• No seizure free period for more than 3 weeks
• No progressive neurological disorder such as a brain tumor, demyelinating disease, and degenerative CNS disease
• No history of status epilepticus, primarily generalized seizures, clustering or nonepileptic seizures
• No history of current serious systemic disease such as liver disease or renal insufficiency, etc.
• No current or past (within 1 year) major psychotic disorder such as schizophrenia, bipolar disorder, etc.
• No planned epilepsy surgery within the next 6 months
• Not currently on the ketogenic diet
• No history of drug or alcohol abuse
• No pregnant or lactating women

If eligible, you will receive investigational drug and study-related medical care at no cost. Compensation for time and travel may also be available.

For additional information about this study or to enroll, visit our website: www.clinicaltrialsinc.com

If you would like to learn more about participating in this study, please send an e-mail message using the form below.